Logo image of FIVE

FIVE BELOW (FIVE) Stock Fundamental Analysis

NASDAQ:FIVE - Nasdaq - US33829M1018 - Common Stock

95.86  +5.22 (+5.76%)

After market: 95 -0.86 (-0.9%)

Fundamental Rating

6

Overall FIVE gets a fundamental rating of 6 out of 10. We evaluated FIVE against 119 industry peers in the Specialty Retail industry. FIVE has an excellent financial health rating, but there are some minor concerns on its profitability. FIVE is not overvalued while it is showing excellent growth. This is an interesting combination. These ratings would make FIVE suitable for growth investing!


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

FIVE had positive earnings in the past year.
FIVE had a positive operating cash flow in the past year.
FIVE had positive earnings in each of the past 5 years.
FIVE had a positive operating cash flow in each of the past 5 years.
FIVE Yearly Net Income VS EBIT VS OCF VS FCFFIVE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

1.2 Ratios

The Return On Assets of FIVE (6.41%) is better than 73.28% of its industry peers.
Looking at the Return On Equity, with a value of 16.61%, FIVE is in the better half of the industry, outperforming 74.14% of the companies in the same industry.
FIVE has a Return On Invested Capital of 7.85%. This is in the better half of the industry: FIVE outperforms 67.24% of its industry peers.
FIVE had an Average Return On Invested Capital over the past 3 years of 11.55%. This is in line with the industry average of 12.38%.
Industry RankSector Rank
ROA 6.41%
ROE 16.61%
ROIC 7.85%
ROA(3y)8.44%
ROA(5y)7.92%
ROE(3y)21.03%
ROE(5y)20.02%
ROIC(3y)11.55%
ROIC(5y)10.28%
FIVE Yearly ROA, ROE, ROICFIVE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

With an excellent Profit Margin value of 7.02%, FIVE belongs to the best of the industry, outperforming 83.62% of the companies in the same industry.
FIVE's Profit Margin has declined in the last couple of years.
FIVE has a Operating Margin of 9.04%. This is amongst the best in the industry. FIVE outperforms 81.90% of its industry peers.
In the last couple of years the Operating Margin of FIVE has declined.
FIVE has a Gross Margin (35.18%) which is in line with its industry peers.
In the last couple of years the Gross Margin of FIVE has remained more or less at the same level.
Industry RankSector Rank
OM 9.04%
PM (TTM) 7.02%
GM 35.18%
OM growth 3Y8.83%
OM growth 5Y-2.03%
PM growth 3Y10.39%
PM growth 5Y-2.48%
GM growth 3Y2.49%
GM growth 5Y-0.25%
FIVE Yearly Profit, Operating, Gross MarginsFIVE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

More info and screens

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), FIVE is creating some value.
FIVE has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, FIVE has less shares outstanding
There is no outstanding debt for FIVE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
FIVE Yearly Shares OutstandingFIVE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
FIVE Yearly Total Debt VS Total AssetsFIVE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

An Altman-Z score of 3.00 indicates that FIVE is not in any danger for bankruptcy at the moment.
FIVE's Altman-Z score of 3.00 is fine compared to the rest of the industry. FIVE outperforms 68.10% of its industry peers.
FIVE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 3
ROIC/WACC0.77
WACC10.23%
FIVE Yearly LT Debt VS Equity VS FCFFIVE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 1.38 indicates that FIVE should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.38, FIVE is in line with its industry, outperforming 49.14% of the companies in the same industry.
FIVE has a Quick Ratio of 1.38. This is a bad value and indicates that FIVE is not financially healthy enough and could expect problems in meeting its short term obligations.
FIVE has a Quick ratio of 0.45. This is comparable to the rest of the industry: FIVE outperforms 44.83% of its industry peers.
Industry RankSector Rank
Current Ratio 1.38
Quick Ratio 0.45
FIVE Yearly Current Assets VS Current LiabilitesFIVE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

7

3. Growth

3.1 Past

FIVE shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 7.64%.
Measured over the past years, FIVE shows a quite strong growth in Earnings Per Share. The EPS has been growing by 15.56% on average per year.
FIVE shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 14.32%.
Measured over the past years, FIVE shows a quite strong growth in Revenue. The Revenue has been growing by 17.94% on average per year.
EPS 1Y (TTM)7.64%
EPS 3Y35.47%
EPS 5Y15.56%
EPS Q2Q%61.54%
Revenue 1Y (TTM)14.32%
Revenue growth 3Y21.96%
Revenue growth 5Y17.94%
Sales Q2Q%14.57%

3.2 Future

Based on estimates for the next years, FIVE will show a very strong growth in Earnings Per Share. The EPS will grow by 25.19% on average per year.
Based on estimates for the next years, FIVE will show a quite strong growth in Revenue. The Revenue will grow by 16.34% on average per year.
EPS Next Y-7.25%
EPS Next 2Y-1.28%
EPS Next 3Y3.46%
EPS Next 5Y25.19%
Revenue Next Year8.13%
Revenue Next 2Y9.17%
Revenue Next 3Y9.52%
Revenue Next 5Y16.34%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
FIVE Yearly Revenue VS EstimatesFIVE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2B 4B 6B 8B
FIVE Yearly EPS VS EstimatesFIVE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 5 10 15 20

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 18.40, FIVE is valued on the expensive side.
Based on the Price/Earnings ratio, FIVE is valued a bit cheaper than 69.83% of the companies in the same industry.
FIVE's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 28.29.
With a Price/Forward Earnings ratio of 18.15, FIVE is valued on the expensive side.
Compared to the rest of the industry, the Price/Forward Earnings ratio of FIVE indicates a somewhat cheap valuation: FIVE is cheaper than 67.24% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of FIVE to the average of the S&P500 Index (24.44), we can say FIVE is valued slightly cheaper.
Industry RankSector Rank
PE 18.4
Fwd PE 18.15
FIVE Price Earnings VS Forward Price EarningsFIVE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 100 200 300

4.2 Price Multiples

FIVE's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. FIVE is cheaper than 62.07% of the companies in the same industry.
FIVE's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 52.81
EV/EBITDA 9.93
FIVE Per share dataFIVE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

FIVE has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)1.18
EPS Next 2Y-1.28%
EPS Next 3Y3.46%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for FIVE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

FIVE BELOW

NASDAQ:FIVE (1/21/2025, 8:00:09 PM)

After market: 95 -0.86 (-0.9%)

95.86

+5.22 (+5.76%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)12-04 2024-12-04/amc
Earnings (Next)N/A N/A
Inst Owners107.6%
Inst Owner Change0.07%
Ins Owners1.66%
Ins Owner Change13.18%
Market Cap5.27B
Analysts71.61
Price Target129.21 (34.79%)
Short Float %8.04%
Short Ratio2.13
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)70.91%
Min EPS beat(2)-2.24%
Max EPS beat(2)144.07%
EPS beat(4)1
Avg EPS beat(4)32.6%
Min EPS beat(4)-6.03%
Max EPS beat(4)144.07%
EPS beat(8)3
Avg EPS beat(8)17.61%
EPS beat(12)4
Avg EPS beat(12)19.23%
EPS beat(16)8
Avg EPS beat(16)19.37%
Revenue beat(2)1
Avg Revenue beat(2)1.49%
Min Revenue beat(2)-1.02%
Max Revenue beat(2)3.99%
Revenue beat(4)1
Avg Revenue beat(4)-1.09%
Min Revenue beat(4)-4.55%
Max Revenue beat(4)3.99%
Revenue beat(8)1
Avg Revenue beat(8)-1.21%
Revenue beat(12)2
Avg Revenue beat(12)-1.39%
Revenue beat(16)5
Avg Revenue beat(16)-0.43%
PT rev (1m)19.98%
PT rev (3m)20.69%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-12.26%
EPS NY rev (1m)0%
EPS NY rev (3m)7.87%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.68%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.99%
Valuation
Industry RankSector Rank
PE 18.4
Fwd PE 18.15
P/S 1.38
P/FCF 52.81
P/OCF 11.11
P/B 3.26
P/tB 3.26
EV/EBITDA 9.93
EPS(TTM)5.21
EY5.44%
EPS(NY)5.28
Fwd EY5.51%
FCF(TTM)1.82
FCFY1.89%
OCF(TTM)8.63
OCFY9%
SpS69.5
BVpS29.37
TBVpS29.37
PEG (NY)N/A
PEG (5Y)1.18
Profitability
Industry RankSector Rank
ROA 6.41%
ROE 16.61%
ROCE 10.44%
ROIC 7.85%
ROICexc 8.39%
ROICexgc 8.39%
OM 9.04%
PM (TTM) 7.02%
GM 35.18%
FCFM 2.61%
ROA(3y)8.44%
ROA(5y)7.92%
ROE(3y)21.03%
ROE(5y)20.02%
ROIC(3y)11.55%
ROIC(5y)10.28%
ROICexc(3y)13.55%
ROICexc(5y)12.25%
ROICexgc(3y)13.55%
ROICexgc(5y)12.25%
ROCE(3y)15.37%
ROCE(5y)13.68%
ROICexcg growth 3Y8.42%
ROICexcg growth 5Y-22.66%
ROICexc growth 3Y8.42%
ROICexc growth 5Y-22.66%
OM growth 3Y8.83%
OM growth 5Y-2.03%
PM growth 3Y10.39%
PM growth 5Y-2.48%
GM growth 3Y2.49%
GM growth 5Y-0.25%
F-Score6
Asset Turnover0.91
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 235.8%
Cap/Sales 9.81%
Interest Coverage 250
Cash Conversion 94.12%
Profit Quality 37.21%
Current Ratio 1.38
Quick Ratio 0.45
Altman-Z 3
F-Score6
WACC10.23%
ROIC/WACC0.77
Cap/Depr(3y)278.25%
Cap/Depr(5y)301.93%
Cap/Sales(3y)9.24%
Cap/Sales(5y)9.88%
Profit Quality(3y)30.98%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)7.64%
EPS 3Y35.47%
EPS 5Y15.56%
EPS Q2Q%61.54%
EPS Next Y-7.25%
EPS Next 2Y-1.28%
EPS Next 3Y3.46%
EPS Next 5Y25.19%
Revenue 1Y (TTM)14.32%
Revenue growth 3Y21.96%
Revenue growth 5Y17.94%
Sales Q2Q%14.57%
Revenue Next Year8.13%
Revenue Next 2Y9.17%
Revenue Next 3Y9.52%
Revenue Next 5Y16.34%
EBIT growth 1Y0.75%
EBIT growth 3Y32.73%
EBIT growth 5Y15.55%
EBIT Next Year29.07%
EBIT Next 3Y16.67%
EBIT Next 5Y24.8%
FCF growth 1Y210.47%
FCF growth 3Y-0.25%
FCF growth 5Y18.51%
OCF growth 1Y200.15%
OCF growth 3Y10.93%
OCF growth 5Y22.1%